A Nature Cell Biology study shows that vitamin B2 metabolism helps cancer cells evade ferroptosis by stabilizing ferroptosis ...

Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

Oregon Therapeutics & Lantern Pharma launch a strategic AI collaboration to optimize XCE853, a novel cancer drug candidate. Demonstrating efficacy in solid and hematological cancers, XCE853 is poised ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. They not only infect and kill cancer cells, but also modulate the tumor micro-environment to enhance ...

Novartis strengthens expands its radioligand therapy arsenal with the acquisition of Mariana Oncology in a $1 billion deal. With this strategic move, Novartis has become a key player in the ...

The Phase III SUNMO trial could mark a breakthrough for transplant-ineligible patients with relapsed or refractory large B-cell lymphoma. In this ONCOLife interview, we spoke with Dr. Jason Westin, ...

The FDA has granted accelerated approval to sevabertinib (Hyrnuo), for previously treated HER2-mutated metastatic non-squamous non-small cell lung cancer, based on strong activity in the Phase I/II ...

ONCOLife proudly presents an exclusive interview with Dr. Joana Reis, Global Medical Affairs Lead, Breast Imaging, Radiology at Bayer. In this session, we explore how AI-driven advancements are ...

Novartis announced that its drug Ribociclib (Kisqali®) combined with endocrine therapy (ET) demonstrates a sustained 28.5% reduction in distant recurrence for high-risk HR+/HER2- early breast cancer ...